Know Cancer

or
forgot password

Management of Advanced Non-Small Cell Lung Cancer and Clinical Outcomes in Patients Who Received Gefitinib (IRESSA) in Tertiary Care Setting in Thailand


N/A
N/A
N/A
Not Enrolling
Both
Lung Cancer

Thank you

Trial Information

Management of Advanced Non-Small Cell Lung Cancer and Clinical Outcomes in Patients Who Received Gefitinib (IRESSA) in Tertiary Care Setting in Thailand


Inclusion Criteria:



- Diagnosed as having lung cancer based on histological/cytological findings

- Admitted to the hospital between January 2004 and December 2008

- Treated with gefitinib for at least 3 months

Exclusion Criteria:

- Involvement in the planning and/or conduct of the study

- Participation in another clinical study during the last 3 months

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Retrospective

Outcome Measure:

Progression-free survival

Outcome Time Frame:

median time from the first date of treatment until date of disease progression during Jan 2004- Dec 2008 or 5 years approx.

Safety Issue:

No

Principal Investigator

Virote Sriuranpong, MD., PhD.

Investigator Role:

Principal Investigator

Investigator Affiliation:

Chulalongkorn Hospital, Bangkok, Thailand

Authority:

Thailand: Ethical Committee

Study ID:

NIS-OTH-IRE-2009/1

NCT ID:

NCT01130961

Start Date:

October 2009

Completion Date:

August 2010

Related Keywords:

  • Lung Cancer
  • Advanced NSCLC
  • Gefitinib
  • Thai patient
  • Carcinoma, Non-Small-Cell Lung
  • Lung Neoplasms

Name

Location